FDA Panel Says Data Don't Show Naproxen Is Safer NSAID
A U.S. Food and Drug Administration panel voted Tuesday that there is not enough scientific proof to support claims that naproxen, a painkiller sold as Aleve by drug giant Bayer Corp.,...To view the full article, register now.
Already a subscriber? Click here to view full article